Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Valve Prosthesis | 12 | 2024 | 1462 | 2.390 |
Why?
|
Fibroblast Growth Factor 2 | 22 | 2006 | 592 | 1.870 |
Why?
|
Aortic Valve Stenosis | 14 | 2023 | 2003 | 1.710 |
Why?
|
Neovascularization, Physiologic | 31 | 2011 | 1349 | 1.650 |
Why?
|
Calcium Phosphates | 6 | 2016 | 171 | 1.590 |
Why?
|
Myocardial Ischemia | 33 | 2014 | 2110 | 1.520 |
Why?
|
Coronary Vessels | 31 | 2019 | 3095 | 1.520 |
Why?
|
Bioprosthesis | 6 | 2024 | 591 | 1.410 |
Why?
|
Prosthesis Failure | 5 | 2024 | 1204 | 1.330 |
Why?
|
Heart Valve Prosthesis Implantation | 13 | 2024 | 1553 | 1.280 |
Why?
|
Lactic Acid | 6 | 2016 | 1139 | 1.180 |
Why?
|
Drug-Eluting Stents | 6 | 2019 | 681 | 1.170 |
Why?
|
Coronary Circulation | 27 | 2019 | 1569 | 1.130 |
Why?
|
Aortic Valve | 13 | 2024 | 1955 | 1.060 |
Why?
|
Stents | 15 | 2019 | 3178 | 1.030 |
Why?
|
Prosthesis Design | 9 | 2024 | 2114 | 1.020 |
Why?
|
Coronary Restenosis | 5 | 2019 | 396 | 0.880 |
Why?
|
Aortic Valve Insufficiency | 2 | 2024 | 576 | 0.850 |
Why?
|
Coronary Disease | 18 | 2010 | 5912 | 0.760 |
Why?
|
Ultrasonography, Interventional | 7 | 2019 | 1496 | 0.680 |
Why?
|
Polymers | 4 | 2015 | 1614 | 0.660 |
Why?
|
Endothelial Growth Factors | 12 | 2003 | 673 | 0.660 |
Why?
|
Absorbable Implants | 3 | 2016 | 338 | 0.650 |
Why?
|
Atherectomy, Coronary | 4 | 2011 | 137 | 0.640 |
Why?
|
Myocardium | 14 | 2013 | 4724 | 0.630 |
Why?
|
Lymphokines | 11 | 2003 | 925 | 0.630 |
Why?
|
Angioplasty, Balloon, Coronary | 9 | 2019 | 1725 | 0.610 |
Why?
|
Swine | 34 | 2016 | 5907 | 0.600 |
Why?
|
Myocardial Revascularization | 6 | 2005 | 790 | 0.600 |
Why?
|
Vascular Endothelial Growth Factor A | 25 | 2012 | 3492 | 0.550 |
Why?
|
Coronary Artery Disease | 16 | 2021 | 6403 | 0.550 |
Why?
|
Angioplasty, Balloon | 2 | 2011 | 589 | 0.530 |
Why?
|
Paclitaxel | 3 | 2015 | 1730 | 0.530 |
Why?
|
Mitral Valve Insufficiency | 5 | 2023 | 1400 | 0.530 |
Why?
|
Collateral Circulation | 15 | 2012 | 293 | 0.530 |
Why?
|
Polyglycolic Acid | 3 | 2014 | 406 | 0.510 |
Why?
|
Heart Septal Defects, Atrial | 4 | 2022 | 451 | 0.510 |
Why?
|
Coronary Angiography | 23 | 2021 | 4470 | 0.500 |
Why?
|
Angiogenesis Inducing Agents | 5 | 2006 | 278 | 0.500 |
Why?
|
Catheterization | 5 | 2011 | 1428 | 0.490 |
Why?
|
Pericardium | 7 | 2005 | 664 | 0.480 |
Why?
|
Nanocapsules | 1 | 2015 | 94 | 0.470 |
Why?
|
Coronary Stenosis | 5 | 2019 | 794 | 0.450 |
Why?
|
Angioplasty | 2 | 2010 | 355 | 0.450 |
Why?
|
Peripheral Vascular Diseases | 3 | 2009 | 488 | 0.450 |
Why?
|
Myocardial Perfusion Imaging | 6 | 2021 | 575 | 0.430 |
Why?
|
Heart Aneurysm | 1 | 2013 | 114 | 0.430 |
Why?
|
Pericardial Effusion | 3 | 2019 | 247 | 0.420 |
Why?
|
Graft Occlusion, Vascular | 2 | 2010 | 537 | 0.410 |
Why?
|
Echocardiography, Three-Dimensional | 4 | 2022 | 607 | 0.410 |
Why?
|
Vasodilation | 8 | 2007 | 962 | 0.400 |
Why?
|
Peripheral Arterial Disease | 3 | 2014 | 1271 | 0.390 |
Why?
|
Treatment Outcome | 43 | 2024 | 64568 | 0.390 |
Why?
|
Radiography, Interventional | 3 | 2013 | 1120 | 0.370 |
Why?
|
Angiogenic Proteins | 3 | 2010 | 101 | 0.370 |
Why?
|
Aorta, Abdominal | 2 | 2010 | 625 | 0.370 |
Why?
|
Aneurysm, False | 1 | 2013 | 255 | 0.370 |
Why?
|
Coated Materials, Biocompatible | 2 | 2019 | 311 | 0.360 |
Why?
|
Stilbenes | 4 | 2012 | 155 | 0.350 |
Why?
|
Tubulin Modulators | 1 | 2010 | 107 | 0.350 |
Why?
|
Foreign-Body Migration | 1 | 2012 | 219 | 0.350 |
Why?
|
Femoral Artery | 2 | 2011 | 826 | 0.340 |
Why?
|
Heart Septum | 1 | 2010 | 299 | 0.340 |
Why?
|
Echocardiography, Transesophageal | 7 | 2024 | 1085 | 0.340 |
Why?
|
Microcirculation | 9 | 2010 | 1272 | 0.330 |
Why?
|
Vascular Endothelial Growth Factors | 12 | 2006 | 748 | 0.330 |
Why?
|
Tissue Scaffolds | 1 | 2016 | 932 | 0.330 |
Why?
|
Iliac Artery | 1 | 2010 | 343 | 0.320 |
Why?
|
Popliteal Artery | 1 | 2011 | 310 | 0.320 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 7 | 2019 | 1068 | 0.320 |
Why?
|
Vena Cava Filters | 1 | 2012 | 261 | 0.320 |
Why?
|
Regional Blood Flow | 3 | 2009 | 1496 | 0.320 |
Why?
|
Vena Cava, Inferior | 1 | 2012 | 458 | 0.320 |
Why?
|
Device Removal | 2 | 2012 | 629 | 0.320 |
Why?
|
Septal Occluder Device | 2 | 2021 | 125 | 0.310 |
Why?
|
Vascular System Injuries | 1 | 2012 | 245 | 0.310 |
Why?
|
Ethanol | 4 | 2013 | 1320 | 0.310 |
Why?
|
Polytetrafluoroethylene | 1 | 2009 | 245 | 0.300 |
Why?
|
Laser Therapy | 4 | 2005 | 1092 | 0.300 |
Why?
|
Heart Ventricles | 4 | 2019 | 3796 | 0.300 |
Why?
|
Natriuretic Agents | 1 | 2008 | 57 | 0.300 |
Why?
|
Cardiomyopathy, Hypertrophic | 2 | 2008 | 1310 | 0.300 |
Why?
|
Injections | 5 | 2005 | 832 | 0.290 |
Why?
|
Intercellular Signaling Peptides and Proteins | 3 | 2003 | 1650 | 0.290 |
Why?
|
Thrombectomy | 2 | 2002 | 702 | 0.290 |
Why?
|
Biocompatible Materials | 3 | 2014 | 1683 | 0.280 |
Why?
|
Arteritis | 1 | 2009 | 158 | 0.280 |
Why?
|
Angina Pectoris | 6 | 2019 | 959 | 0.270 |
Why?
|
Renal Artery Obstruction | 1 | 2008 | 219 | 0.270 |
Why?
|
Ischemia | 2 | 2008 | 1884 | 0.260 |
Why?
|
Vasodilator Agents | 5 | 2010 | 973 | 0.260 |
Why?
|
Echocardiography | 5 | 2023 | 4987 | 0.260 |
Why?
|
Gene Transfer Techniques | 2 | 2001 | 1202 | 0.260 |
Why?
|
Aorta, Thoracic | 1 | 2012 | 1096 | 0.250 |
Why?
|
Coronary Artery Bypass | 7 | 2008 | 2188 | 0.250 |
Why?
|
Myocardial Infarction | 9 | 2010 | 11459 | 0.250 |
Why?
|
Syncope | 1 | 2008 | 428 | 0.240 |
Why?
|
Pulmonary Edema | 1 | 2008 | 407 | 0.240 |
Why?
|
Ventricular Function, Left | 6 | 2012 | 3873 | 0.240 |
Why?
|
Heart Block | 1 | 2006 | 384 | 0.240 |
Why?
|
Hypercholesterolemia | 5 | 2012 | 1141 | 0.220 |
Why?
|
Atrial Septum | 2 | 2022 | 60 | 0.220 |
Why?
|
Coronary Aneurysm | 1 | 2006 | 232 | 0.220 |
Why?
|
Humans | 107 | 2024 | 760617 | 0.220 |
Why?
|
Male | 78 | 2024 | 360358 | 0.220 |
Why?
|
Instillation, Drug | 1 | 2003 | 32 | 0.220 |
Why?
|
Sirolimus | 1 | 2010 | 1533 | 0.220 |
Why?
|
Drug Delivery Systems | 4 | 2006 | 2222 | 0.220 |
Why?
|
Animals | 56 | 2016 | 168201 | 0.220 |
Why?
|
Heart Atria | 3 | 2019 | 1333 | 0.210 |
Why?
|
Recovery of Function | 4 | 2019 | 2978 | 0.210 |
Why?
|
Coronary Thrombosis | 2 | 2002 | 440 | 0.210 |
Why?
|
Leg | 1 | 2008 | 1087 | 0.210 |
Why?
|
Saphenous Vein | 3 | 2002 | 516 | 0.200 |
Why?
|
Skin Transplantation | 1 | 2007 | 1083 | 0.200 |
Why?
|
Heart Diseases | 4 | 2022 | 2778 | 0.190 |
Why?
|
Regeneration | 1 | 2010 | 1505 | 0.190 |
Why?
|
Exercise Therapy | 1 | 2008 | 929 | 0.190 |
Why?
|
Materials Testing | 3 | 2015 | 862 | 0.190 |
Why?
|
Geriatric Assessment | 2 | 2019 | 1411 | 0.190 |
Why?
|
Aortic Aneurysm | 1 | 2006 | 648 | 0.190 |
Why?
|
Injections, Intravenous | 2 | 2003 | 1376 | 0.190 |
Why?
|
Hepatocyte Growth Factor | 1 | 2003 | 271 | 0.190 |
Why?
|
Electrophysiology | 2 | 2023 | 1262 | 0.190 |
Why?
|
Blood Vessel Prosthesis Implantation | 4 | 2005 | 1426 | 0.180 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2009 | 2008 | 0.180 |
Why?
|
Fibroblast Growth Factors | 2 | 2003 | 865 | 0.170 |
Why?
|
Aged | 43 | 2024 | 169042 | 0.170 |
Why?
|
Dyspnea | 1 | 2008 | 1347 | 0.170 |
Why?
|
Myocardial Reperfusion | 3 | 2013 | 338 | 0.170 |
Why?
|
Blood Vessel Prosthesis | 2 | 2016 | 951 | 0.170 |
Why?
|
Feasibility Studies | 5 | 2023 | 5239 | 0.170 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2002 | 577 | 0.170 |
Why?
|
Recurrence | 4 | 2024 | 8426 | 0.170 |
Why?
|
Pericardiectomy | 1 | 2019 | 46 | 0.160 |
Why?
|
Pericardiocentesis | 1 | 2019 | 77 | 0.160 |
Why?
|
Hemodynamics | 10 | 2017 | 4160 | 0.160 |
Why?
|
Foramen Ovale, Patent | 1 | 2022 | 208 | 0.160 |
Why?
|
Drug Implants | 2 | 2015 | 230 | 0.160 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2008 | 1723 | 0.160 |
Why?
|
Disease Models, Animal | 17 | 2012 | 18221 | 0.160 |
Why?
|
Polyesters | 3 | 2015 | 371 | 0.160 |
Why?
|
Infusions, Intravenous | 7 | 2008 | 2214 | 0.160 |
Why?
|
Needles | 1 | 2002 | 450 | 0.160 |
Why?
|
Myocardial Contraction | 4 | 2002 | 1515 | 0.160 |
Why?
|
Activities of Daily Living | 4 | 2020 | 2417 | 0.150 |
Why?
|
Swine, Miniature | 8 | 2014 | 961 | 0.150 |
Why?
|
Female | 63 | 2023 | 392148 | 0.150 |
Why?
|
Fistula | 1 | 2019 | 212 | 0.150 |
Why?
|
Endovascular Procedures | 1 | 2012 | 2182 | 0.150 |
Why?
|
Delirium | 2 | 2020 | 1665 | 0.150 |
Why?
|
Fluoroscopy | 3 | 2013 | 945 | 0.150 |
Why?
|
Bronchial Fistula | 1 | 2018 | 83 | 0.140 |
Why?
|
Catheter Ablation | 3 | 2008 | 2634 | 0.140 |
Why?
|
Tomography, X-Ray Computed | 8 | 2021 | 20556 | 0.140 |
Why?
|
Mitral Valve | 5 | 2023 | 1464 | 0.140 |
Why?
|
Drainage | 2 | 2019 | 1156 | 0.140 |
Why?
|
Rats, Sprague-Dawley | 5 | 2014 | 8166 | 0.140 |
Why?
|
Gastric Fistula | 1 | 2018 | 73 | 0.140 |
Why?
|
Pilot Projects | 3 | 2023 | 8618 | 0.140 |
Why?
|
Cyclooxygenase 2 | 3 | 2010 | 596 | 0.140 |
Why?
|
Follow-Up Studies | 16 | 2023 | 39063 | 0.140 |
Why?
|
Heart | 6 | 2012 | 4403 | 0.140 |
Why?
|
Pacemaker, Artificial | 1 | 2022 | 805 | 0.140 |
Why?
|
Thrombosis | 1 | 2010 | 2943 | 0.140 |
Why?
|
Endothelium, Vascular | 7 | 2012 | 4433 | 0.140 |
Why?
|
Ultrasonography | 2 | 2019 | 5964 | 0.140 |
Why?
|
Hemoptysis | 1 | 2018 | 151 | 0.140 |
Why?
|
Rats | 7 | 2014 | 23717 | 0.130 |
Why?
|
Gastroscopy | 1 | 2018 | 211 | 0.130 |
Why?
|
Catheters | 1 | 2019 | 423 | 0.130 |
Why?
|
Extremities | 1 | 2001 | 867 | 0.130 |
Why?
|
Models, Anatomic | 1 | 2019 | 683 | 0.130 |
Why?
|
Carotid Artery, Internal | 1 | 2018 | 445 | 0.130 |
Why?
|
Tricuspid Valve | 1 | 2018 | 409 | 0.130 |
Why?
|
Predictive Value of Tests | 9 | 2021 | 15251 | 0.120 |
Why?
|
Neovascularization, Pathologic | 1 | 2006 | 2644 | 0.120 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2019 | 10199 | 0.120 |
Why?
|
Aged, 80 and over | 17 | 2023 | 58894 | 0.120 |
Why?
|
Random Allocation | 4 | 2011 | 2392 | 0.120 |
Why?
|
Bone Marrow Transplantation | 1 | 2003 | 2690 | 0.120 |
Why?
|
Angiostatins | 3 | 2010 | 64 | 0.120 |
Why?
|
Autoradiography | 3 | 2005 | 728 | 0.120 |
Why?
|
Tissue Distribution | 3 | 2005 | 2261 | 0.120 |
Why?
|
Retreatment | 2 | 2018 | 596 | 0.120 |
Why?
|
Postoperative Hemorrhage | 1 | 2018 | 414 | 0.110 |
Why?
|
Atrial Appendage | 1 | 2018 | 278 | 0.110 |
Why?
|
Metals | 2 | 2011 | 719 | 0.110 |
Why?
|
Skin | 1 | 2007 | 4473 | 0.110 |
Why?
|
Endothelial Cells | 6 | 2007 | 3548 | 0.110 |
Why?
|
Time Factors | 12 | 2019 | 39913 | 0.110 |
Why?
|
Equipment Failure Analysis | 1 | 2016 | 843 | 0.110 |
Why?
|
Middle Aged | 37 | 2019 | 220584 | 0.100 |
Why?
|
Positron-Emission Tomography | 1 | 2009 | 6483 | 0.100 |
Why?
|
Prospective Studies | 15 | 2023 | 54360 | 0.100 |
Why?
|
Heparin | 5 | 2005 | 1632 | 0.100 |
Why?
|
Cardiac Imaging Techniques | 1 | 2014 | 266 | 0.100 |
Why?
|
Angiogenesis Inhibitors | 2 | 2010 | 2048 | 0.100 |
Why?
|
Vascular Diseases | 1 | 2000 | 1160 | 0.100 |
Why?
|
Wine | 1 | 2012 | 166 | 0.100 |
Why?
|
Bronchoscopy | 1 | 2018 | 909 | 0.100 |
Why?
|
Infusions, Intra-Arterial | 6 | 2002 | 221 | 0.100 |
Why?
|
Risk Factors | 10 | 2023 | 74115 | 0.090 |
Why?
|
Endostatins | 2 | 2008 | 168 | 0.090 |
Why?
|
Transplantation, Autologous | 2 | 2010 | 2112 | 0.090 |
Why?
|
Anesthesia | 1 | 2022 | 1591 | 0.090 |
Why?
|
Phlebography | 1 | 2012 | 326 | 0.090 |
Why?
|
Alcoholic Beverages | 1 | 2012 | 264 | 0.090 |
Why?
|
Heart Valve Diseases | 1 | 2018 | 1028 | 0.090 |
Why?
|
Time | 2 | 2002 | 545 | 0.090 |
Why?
|
Recombinant Proteins | 5 | 2005 | 6520 | 0.090 |
Why?
|
Naproxen | 1 | 2010 | 100 | 0.090 |
Why?
|
Aortography | 1 | 2012 | 421 | 0.090 |
Why?
|
Tissue Transplantation | 1 | 2010 | 128 | 0.090 |
Why?
|
Acute Disease | 4 | 2010 | 7237 | 0.090 |
Why?
|
Neointima | 1 | 2010 | 133 | 0.090 |
Why?
|
Neuropeptide Y | 1 | 2010 | 192 | 0.080 |
Why?
|
Ligation | 2 | 2007 | 447 | 0.080 |
Why?
|
Longitudinal Studies | 2 | 2016 | 14591 | 0.080 |
Why?
|
Arteries | 3 | 2003 | 1122 | 0.080 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2014 | 851 | 0.080 |
Why?
|
Quality of Life | 5 | 2023 | 13347 | 0.080 |
Why?
|
Solubility | 1 | 2010 | 1089 | 0.080 |
Why?
|
Postoperative Complications | 3 | 2019 | 15612 | 0.080 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2010 | 361 | 0.080 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2010 | 944 | 0.080 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2010 | 321 | 0.080 |
Why?
|
Embolization, Therapeutic | 1 | 2018 | 1418 | 0.080 |
Why?
|
Intracranial Aneurysm | 1 | 2018 | 1285 | 0.080 |
Why?
|
Oxidative Stress | 4 | 2012 | 3113 | 0.080 |
Why?
|
Technetium Tc 99m Mertiatide | 1 | 2008 | 21 | 0.080 |
Why?
|
Exercise Test | 4 | 2005 | 2127 | 0.080 |
Why?
|
Sensitivity and Specificity | 6 | 2019 | 14648 | 0.080 |
Why?
|
Cardiac Surgical Procedures | 1 | 2023 | 3621 | 0.070 |
Why?
|
Blotting, Western | 4 | 2012 | 5034 | 0.070 |
Why?
|
Surface Properties | 1 | 2010 | 1161 | 0.070 |
Why?
|
Hypertension | 1 | 2008 | 8529 | 0.070 |
Why?
|
Antineoplastic Agents | 1 | 2010 | 13635 | 0.070 |
Why?
|
Clinical Trials as Topic | 4 | 2023 | 7995 | 0.070 |
Why?
|
Constriction, Pathologic | 2 | 2023 | 1096 | 0.070 |
Why?
|
Severity of Illness Index | 6 | 2019 | 15828 | 0.070 |
Why?
|
Nitroprusside | 3 | 2006 | 272 | 0.070 |
Why?
|
Thoracotomy | 2 | 2005 | 366 | 0.070 |
Why?
|
Diet, Carbohydrate-Restricted | 1 | 2009 | 262 | 0.070 |
Why?
|
Counterpulsation | 1 | 2005 | 16 | 0.060 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 2 | 2006 | 682 | 0.060 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2008 | 546 | 0.060 |
Why?
|
Angioplasty, Laser | 1 | 2005 | 17 | 0.060 |
Why?
|
Radionuclide Imaging | 2 | 2008 | 1972 | 0.060 |
Why?
|
Blood Flow Velocity | 2 | 2008 | 1370 | 0.060 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2005 | 146 | 0.060 |
Why?
|
Kidney Function Tests | 1 | 2008 | 678 | 0.060 |
Why?
|
Intermittent Claudication | 1 | 2008 | 304 | 0.060 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2008 | 558 | 0.060 |
Why?
|
Organ Culture Techniques | 1 | 2007 | 794 | 0.060 |
Why?
|
Equipment Design | 2 | 2004 | 3501 | 0.060 |
Why?
|
Adenosine Diphosphate | 3 | 2006 | 422 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 9 | 2012 | 36402 | 0.060 |
Why?
|
Pressure | 1 | 2008 | 1150 | 0.060 |
Why?
|
Cell Hypoxia | 2 | 2004 | 656 | 0.060 |
Why?
|
Heart Arrest, Induced | 1 | 2006 | 358 | 0.060 |
Why?
|
Chemokines, CXC | 1 | 2006 | 416 | 0.060 |
Why?
|
Drug Combinations | 1 | 2010 | 2048 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2003 | 5672 | 0.060 |
Why?
|
Antioxidants | 1 | 2012 | 1668 | 0.060 |
Why?
|
Heptanoic Acids | 1 | 2006 | 344 | 0.060 |
Why?
|
Nitroglycerin | 2 | 2003 | 329 | 0.060 |
Why?
|
Carcinoma, Renal Cell | 1 | 2019 | 3164 | 0.060 |
Why?
|
Endocardium | 1 | 2005 | 246 | 0.060 |
Why?
|
Nitric Oxide Synthase Type III | 4 | 2012 | 705 | 0.060 |
Why?
|
Chronic Disease | 6 | 2010 | 9311 | 0.060 |
Why?
|
Echocardiography, Doppler | 1 | 2008 | 893 | 0.060 |
Why?
|
Fatal Outcome | 2 | 2019 | 1835 | 0.060 |
Why?
|
Nitric Oxide Synthase | 3 | 2004 | 908 | 0.050 |
Why?
|
Double-Blind Method | 5 | 2005 | 12334 | 0.050 |
Why?
|
Sulfonamides | 2 | 2010 | 1977 | 0.050 |
Why?
|
Adenosine | 3 | 2003 | 805 | 0.050 |
Why?
|
Reproducibility of Results | 4 | 2019 | 20074 | 0.050 |
Why?
|
Kinetics | 1 | 2010 | 6370 | 0.050 |
Why?
|
Hexuronic Acids | 2 | 1999 | 145 | 0.050 |
Why?
|
Glucuronic Acid | 2 | 1999 | 150 | 0.050 |
Why?
|
Xiphoid Bone | 1 | 2002 | 10 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2019 | 4250 | 0.050 |
Why?
|
Exercise Tolerance | 2 | 2005 | 836 | 0.050 |
Why?
|
Nanoparticles | 1 | 2014 | 1957 | 0.050 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 318 | 0.050 |
Why?
|
Cell Proliferation | 2 | 2008 | 10432 | 0.050 |
Why?
|
Angiography | 1 | 2008 | 1596 | 0.050 |
Why?
|
Electrocardiography | 3 | 2006 | 6346 | 0.050 |
Why?
|
Survival Analysis | 3 | 2017 | 10073 | 0.050 |
Why?
|
Gene Expression Regulation | 5 | 2012 | 11874 | 0.050 |
Why?
|
Diabetes Complications | 1 | 2008 | 1315 | 0.050 |
Why?
|
Internship and Residency | 1 | 2022 | 5878 | 0.050 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2004 | 352 | 0.050 |
Why?
|
Radiography | 4 | 2014 | 6961 | 0.050 |
Why?
|
Receptors, CXCR4 | 1 | 2006 | 727 | 0.050 |
Why?
|
Iodine Radioisotopes | 1 | 2005 | 1031 | 0.050 |
Why?
|
Receptors, Mitogen | 1 | 2001 | 61 | 0.050 |
Why?
|
Research Design | 2 | 2011 | 6174 | 0.050 |
Why?
|
Surgical Instruments | 1 | 2023 | 383 | 0.050 |
Why?
|
Placebo Effect | 1 | 2005 | 518 | 0.050 |
Why?
|
Alginates | 2 | 1999 | 248 | 0.050 |
Why?
|
Dietary Fats | 1 | 2009 | 1995 | 0.050 |
Why?
|
Muscle Development | 1 | 2003 | 259 | 0.050 |
Why?
|
Hospital Mortality | 2 | 2006 | 5293 | 0.040 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 2270 | 0.040 |
Why?
|
Canada | 2 | 2019 | 2118 | 0.040 |
Why?
|
Creatine Kinase | 1 | 2002 | 685 | 0.040 |
Why?
|
Prognosis | 6 | 2021 | 29600 | 0.040 |
Why?
|
Medicare | 1 | 2018 | 6765 | 0.040 |
Why?
|
Pyrazoles | 1 | 2010 | 2008 | 0.040 |
Why?
|
Receptors, Growth Factor | 1 | 2001 | 326 | 0.040 |
Why?
|
Sus scrofa | 2 | 2012 | 428 | 0.040 |
Why?
|
Pyrroles | 1 | 2006 | 1125 | 0.040 |
Why?
|
Transduction, Genetic | 1 | 2003 | 901 | 0.040 |
Why?
|
Punctures | 1 | 2021 | 364 | 0.040 |
Why?
|
Safety | 3 | 1999 | 1149 | 0.040 |
Why?
|
Forecasting | 3 | 2006 | 2924 | 0.040 |
Why?
|
Catheters, Indwelling | 1 | 2002 | 426 | 0.040 |
Why?
|
Cardiovascular Agents | 1 | 2006 | 839 | 0.040 |
Why?
|
Arterioles | 2 | 2013 | 250 | 0.040 |
Why?
|
Boston | 2 | 2002 | 9313 | 0.040 |
Why?
|
Drug Administration Routes | 1 | 1999 | 150 | 0.040 |
Why?
|
Fibroblast Growth Factor 1 | 1 | 1999 | 56 | 0.040 |
Why?
|
Radiopharmaceuticals | 1 | 2009 | 2650 | 0.040 |
Why?
|
Body Surface Potential Mapping | 1 | 2000 | 223 | 0.040 |
Why?
|
Prevalence | 3 | 2019 | 15689 | 0.040 |
Why?
|
RNA, Messenger | 4 | 2008 | 12758 | 0.040 |
Why?
|
Delayed-Action Preparations | 2 | 1999 | 962 | 0.040 |
Why?
|
Veins | 1 | 2003 | 767 | 0.040 |
Why?
|
Growth Substances | 1 | 2001 | 768 | 0.040 |
Why?
|
Isoenzymes | 1 | 2003 | 1687 | 0.040 |
Why?
|
Cohort Studies | 5 | 2020 | 41457 | 0.040 |
Why?
|
Drug Compounding | 1 | 1999 | 245 | 0.040 |
Why?
|
Patient Advocacy | 1 | 2001 | 360 | 0.040 |
Why?
|
Image Enhancement | 1 | 2009 | 2881 | 0.040 |
Why?
|
France | 1 | 2019 | 492 | 0.040 |
Why?
|
Drug Carriers | 2 | 1999 | 706 | 0.040 |
Why?
|
Administration, Topical | 1 | 2000 | 703 | 0.040 |
Why?
|
Immunoblotting | 2 | 2011 | 1646 | 0.040 |
Why?
|
Tachyphylaxis | 1 | 1997 | 54 | 0.040 |
Why?
|
Stem Cell Transplantation | 1 | 2006 | 1600 | 0.040 |
Why?
|
Cell Survival | 1 | 2007 | 5780 | 0.040 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2003 | 1626 | 0.040 |
Why?
|
Amiodarone | 1 | 1999 | 217 | 0.040 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 1998 | 517 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2003 | 15498 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 1997 | 6807 | 0.030 |
Why?
|
Models, Animal | 1 | 2003 | 2109 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2001 | 1697 | 0.030 |
Why?
|
Models, Cardiovascular | 3 | 2012 | 981 | 0.030 |
Why?
|
Gene Expression | 3 | 2005 | 7568 | 0.030 |
Why?
|
Syndrome | 1 | 2002 | 3268 | 0.030 |
Why?
|
Perfusion | 2 | 2010 | 1373 | 0.030 |
Why?
|
Heart Rate | 3 | 2010 | 4180 | 0.030 |
Why?
|
Vascular Resistance | 1 | 1998 | 930 | 0.030 |
Why?
|
Ethics, Medical | 1 | 2001 | 783 | 0.030 |
Why?
|
Apoptosis | 3 | 2010 | 9476 | 0.030 |
Why?
|
Placebos | 1 | 1999 | 1667 | 0.030 |
Why?
|
Anti-Arrhythmia Agents | 1 | 1999 | 763 | 0.030 |
Why?
|
Subtraction Technique | 1 | 1997 | 512 | 0.030 |
Why?
|
Cardiac Tamponade | 1 | 1996 | 173 | 0.030 |
Why?
|
Calorimetry, Differential Scanning | 1 | 2014 | 100 | 0.030 |
Why?
|
Myocytes, Cardiac | 1 | 2003 | 1667 | 0.030 |
Why?
|
Proteoglycans | 1 | 1997 | 803 | 0.030 |
Why?
|
Matrix Metalloproteinase 9 | 2 | 2008 | 632 | 0.030 |
Why?
|
Capillaries | 2 | 2010 | 756 | 0.030 |
Why?
|
Probability | 1 | 2019 | 2475 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2002 | 8516 | 0.030 |
Why?
|
Caspase 3 | 2 | 2006 | 731 | 0.030 |
Why?
|
Diet, Atherogenic | 1 | 2012 | 92 | 0.030 |
Why?
|
Phosphorylation | 3 | 2011 | 8311 | 0.030 |
Why?
|
Cerebral Angiography | 1 | 2018 | 1281 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2010 | 10754 | 0.030 |
Why?
|
Caspases | 2 | 2006 | 878 | 0.020 |
Why?
|
Enzyme Induction | 1 | 2012 | 452 | 0.020 |
Why?
|
Thallium Radioisotopes | 2 | 2002 | 138 | 0.020 |
Why?
|
Receptors, Fibroblast Growth Factor | 2 | 2003 | 191 | 0.020 |
Why?
|
Nitric Oxide | 3 | 2006 | 2135 | 0.020 |
Why?
|
Membrane Proteins | 2 | 2005 | 7847 | 0.020 |
Why?
|
Technetium Tc 99m Sestamibi | 2 | 2002 | 174 | 0.020 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2006 | 3244 | 0.020 |
Why?
|
Embolism | 1 | 1994 | 399 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2001 | 3392 | 0.020 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2003 | 257 | 0.020 |
Why?
|
Singapore | 1 | 2011 | 292 | 0.020 |
Why?
|
Patient Selection | 2 | 2000 | 4237 | 0.020 |
Why?
|
Outpatients | 1 | 1999 | 1596 | 0.020 |
Why?
|
Hospital Costs | 1 | 1997 | 947 | 0.020 |
Why?
|
Preoperative Care | 1 | 2019 | 2241 | 0.020 |
Why?
|
Cholesterol, Dietary | 1 | 2010 | 224 | 0.020 |
Why?
|
Nitroarginine | 2 | 2001 | 66 | 0.020 |
Why?
|
Adult | 9 | 2022 | 220969 | 0.020 |
Why?
|
Heart Function Tests | 1 | 2010 | 318 | 0.020 |
Why?
|
Atrial Fibrillation | 2 | 2018 | 5031 | 0.020 |
Why?
|
Signal Transduction | 4 | 2010 | 23416 | 0.020 |
Why?
|
Anticoagulants | 1 | 2005 | 4785 | 0.020 |
Why?
|
Prostaglandins | 1 | 2010 | 398 | 0.020 |
Why?
|
Blood Chemical Analysis | 1 | 2011 | 436 | 0.020 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 2 | 2004 | 664 | 0.020 |
Why?
|
Cardiology | 1 | 2000 | 1656 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2004 | 5789 | 0.020 |
Why?
|
Collagen Type XVIII | 1 | 2008 | 52 | 0.020 |
Why?
|
Cathepsin L | 1 | 2008 | 69 | 0.020 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 1 | 2008 | 72 | 0.020 |
Why?
|
RNA | 1 | 1998 | 2713 | 0.020 |
Why?
|
Plasminogen | 1 | 2008 | 144 | 0.020 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2012 | 852 | 0.020 |
Why?
|
Curriculum | 1 | 2022 | 3738 | 0.020 |
Why?
|
Cattle | 2 | 2004 | 3841 | 0.020 |
Why?
|
Tomography, Emission-Computed | 2 | 2002 | 1122 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2012 | 2467 | 0.020 |
Why?
|
Cause of Death | 1 | 2018 | 3683 | 0.020 |
Why?
|
Rabbits | 1 | 2014 | 4770 | 0.020 |
Why?
|
Cathepsins | 1 | 2008 | 241 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2003 | 4947 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2002 | 3527 | 0.020 |
Why?
|
Brazil | 1 | 2011 | 1228 | 0.020 |
Why?
|
Japan | 1 | 2011 | 1372 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2011 | 11069 | 0.020 |
Why?
|
Vasoconstrictor Agents | 1 | 2010 | 654 | 0.020 |
Why?
|
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 2006 | 65 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 1997 | 3688 | 0.020 |
Why?
|
Neoplasms | 1 | 1996 | 22131 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2004 | 9586 | 0.020 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2008 | 459 | 0.020 |
Why?
|
Apoptosis Inducing Factor | 1 | 2006 | 51 | 0.020 |
Why?
|
Risk Assessment | 1 | 2008 | 23972 | 0.020 |
Why?
|
Microvessels | 1 | 2010 | 577 | 0.020 |
Why?
|
Nitrobenzenes | 1 | 2005 | 66 | 0.020 |
Why?
|
United States | 4 | 2019 | 72272 | 0.020 |
Why?
|
Cysteine Endopeptidases | 1 | 2008 | 552 | 0.020 |
Why?
|
Anthracenes | 1 | 2005 | 83 | 0.020 |
Why?
|
Receptor, TIE-2 | 1 | 2006 | 176 | 0.020 |
Why?
|
Butadienes | 1 | 2005 | 107 | 0.020 |
Why?
|
ROC Curve | 1 | 2013 | 3575 | 0.020 |
Why?
|
RNA, Small Interfering | 2 | 2005 | 3419 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13245 | 0.020 |
Why?
|
Age Factors | 1 | 2002 | 18381 | 0.020 |
Why?
|
Cadherins | 1 | 2010 | 901 | 0.020 |
Why?
|
Survival Rate | 2 | 1998 | 12719 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2021 | 80566 | 0.020 |
Why?
|
Registries | 1 | 2021 | 8207 | 0.010 |
Why?
|
Europe | 1 | 2011 | 3413 | 0.010 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2011 | 1222 | 0.010 |
Why?
|
Chemokine CXCL12 | 1 | 2006 | 454 | 0.010 |
Why?
|
Transcription Factors | 1 | 2004 | 12116 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2000 | 8998 | 0.010 |
Why?
|
Reference Values | 1 | 2011 | 4919 | 0.010 |
Why?
|
Metformin | 1 | 2012 | 906 | 0.010 |
Why?
|
Kidney | 1 | 1999 | 7045 | 0.010 |
Why?
|
Sp1 Transcription Factor | 1 | 2004 | 140 | 0.010 |
Why?
|
Vasoconstriction | 1 | 2006 | 592 | 0.010 |
Why?
|
Heart Failure | 1 | 2008 | 11669 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2012 | 2057 | 0.010 |
Why?
|
Administration, Oral | 1 | 2011 | 4010 | 0.010 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2004 | 198 | 0.010 |
Why?
|
Mice | 2 | 2008 | 81368 | 0.010 |
Why?
|
In Situ Nick-End Labeling | 1 | 2004 | 613 | 0.010 |
Why?
|
Umbilical Veins | 1 | 2003 | 426 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2004 | 1545 | 0.010 |
Why?
|
Macrophages | 1 | 1997 | 5758 | 0.010 |
Why?
|
Medical Staff, Hospital | 1 | 2006 | 601 | 0.010 |
Why?
|
Epoprostenol | 1 | 2003 | 247 | 0.010 |
Why?
|
Culture Media, Conditioned | 1 | 2003 | 522 | 0.010 |
Why?
|
Inflammation Mediators | 1 | 2010 | 1884 | 0.010 |
Why?
|
Plaque, Atherosclerotic | 1 | 2013 | 1532 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16571 | 0.010 |
Why?
|
Stroke Volume | 3 | 2000 | 5486 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2011 | 6305 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2006 | 1333 | 0.010 |
Why?
|
Cardiopulmonary Bypass | 1 | 2006 | 1092 | 0.010 |
Why?
|
Metabolic Clearance Rate | 1 | 2001 | 361 | 0.010 |
Why?
|
Incidence | 1 | 2019 | 21337 | 0.010 |
Why?
|
Nitriles | 1 | 2005 | 971 | 0.010 |
Why?
|
Dogs | 1 | 2005 | 3838 | 0.010 |
Why?
|
Dinoprostone | 1 | 2003 | 597 | 0.010 |
Why?
|
Regression Analysis | 2 | 2001 | 6338 | 0.010 |
Why?
|
DNA Probes | 1 | 2001 | 541 | 0.010 |
Why?
|
Substance P | 1 | 2001 | 335 | 0.010 |
Why?
|
Blood Pressure | 2 | 2010 | 8472 | 0.010 |
Why?
|
Antigens, CD | 1 | 2010 | 3998 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2006 | 1404 | 0.010 |
Why?
|
Imidazoles | 1 | 2005 | 1175 | 0.010 |
Why?
|
Disease Progression | 1 | 1996 | 13495 | 0.010 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2001 | 326 | 0.010 |
Why?
|
MAP Kinase Signaling System | 1 | 2006 | 1483 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2005 | 18937 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2012 | 3085 | 0.010 |
Why?
|
Injections, Intra-Arterial | 1 | 1998 | 181 | 0.010 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2004 | 1134 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2003 | 1169 | 0.010 |
Why?
|
Linear Models | 1 | 2008 | 5866 | 0.010 |
Why?
|
Maximum Tolerated Dose | 1 | 2001 | 883 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2006 | 1971 | 0.010 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2001 | 629 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2004 | 3591 | 0.010 |
Why?
|
Mitochondrial Proteins | 1 | 2004 | 974 | 0.010 |
Why?
|
Infusion Pumps, Implantable | 1 | 1998 | 158 | 0.010 |
Why?
|
Gene Deletion | 1 | 2005 | 2661 | 0.010 |
Why?
|
Syndecans | 1 | 1997 | 75 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2006 | 2456 | 0.010 |
Why?
|
Cholesterol | 1 | 2006 | 2903 | 0.010 |
Why?
|
Syndecan-1 | 1 | 1997 | 163 | 0.010 |
Why?
|
Area Under Curve | 1 | 2001 | 1635 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2004 | 2100 | 0.010 |
Why?
|
Eye Diseases | 1 | 2002 | 653 | 0.010 |
Why?
|
Electrocardiography, Ambulatory | 1 | 1999 | 574 | 0.010 |
Why?
|
Transfection | 1 | 2004 | 5766 | 0.010 |
Why?
|
Hypotension | 1 | 2002 | 878 | 0.010 |
Why?
|
Rest | 1 | 2000 | 918 | 0.010 |
Why?
|
Echo-Planar Imaging | 1 | 2000 | 663 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2000 | 1700 | 0.010 |
Why?
|
Microspheres | 1 | 1997 | 782 | 0.010 |
Why?
|
Biosensing Techniques | 1 | 2000 | 647 | 0.010 |
Why?
|
Models, Biological | 1 | 2010 | 9461 | 0.010 |
Why?
|
Algorithms | 1 | 2014 | 14018 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2001 | 3800 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 4570 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2004 | 2872 | 0.010 |
Why?
|
Pyridines | 1 | 2005 | 2874 | 0.010 |
Why?
|
Angina, Unstable | 1 | 1998 | 888 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 1997 | 1900 | 0.010 |
Why?
|
Stress, Physiological | 1 | 2000 | 1403 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 1998 | 2849 | 0.010 |
Why?
|
Adolescent | 1 | 2001 | 88234 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2004 | 5780 | 0.010 |
Why?
|
Serotonin | 1 | 1997 | 1041 | 0.010 |
Why?
|
Creatinine | 1 | 1998 | 1896 | 0.010 |
Why?
|
Secondary Prevention | 1 | 1999 | 1469 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2004 | 13441 | 0.010 |
Why?
|
Phantoms, Imaging | 1 | 2000 | 2518 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2004 | 17629 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2004 | 4935 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2001 | 3705 | 0.010 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2001 | 2118 | 0.010 |
Why?
|
Cell Line | 1 | 2003 | 15576 | 0.010 |
Why?
|
Proteins | 1 | 2004 | 6030 | 0.010 |
Why?
|
Health Status | 1 | 2002 | 4075 | 0.000 |
Why?
|
Hospitalization | 1 | 2006 | 10704 | 0.000 |
Why?
|
Cell Movement | 1 | 1997 | 5200 | 0.000 |
Why?
|
Cost-Benefit Analysis | 1 | 1997 | 5491 | 0.000 |
Why?
|